EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis

Vu L Tran iD, Adrian Gervais iD, Marie-Mechtilde Champeaux iD, Maria Paula de Souza Sampaio iD, Sylvie Abel, Isabelle Calmont, Mateus Santana do Rosario iD, Laire Schidlowski, Jordan D Simione iD, Pedro Augusto Alves iD, Anne Puel iD, Paul Bastard iD und 8 weitere

Proceedings of the National Academy of Sciences · 25.08.2026 · 123 (34)

DOI: 10.1073/pnas.2616897123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.08.2026. Verfasst von Vu L Tran und 19 weiteren Autor:innen. Beteiligte Einrichtung: St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY 10065. Hauptthemen laut MEDLINE: Autoantibodies, Chikungunya virus, Interferon Type I, Chikungunya Fever. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon Europe, NCATS NIH HHS, French National Agency for Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) infection is typically not life threatening but may, in rare cases, affect the central nervous system (CNS). In three cohorts of confirmed CHIKV cases from Martinique (French overseas territory) and Brazil (patients aged 0 to 89 y, n = 245), 20 patients had CNS infection (aged 17 to 87 y). Autoantibodies neutralizing type I interferons (AAN-I-IFN) were found in 35% of patients (4 male and 3 female, aged 17 to 87 y) with encephalitis (4/15), encephalomyelitis (1/2), or myelitis (2/3), but were absent in 225 patients without CNS infection. They neutralized high concentrations (10 to 1,000 ng/mL) of IFN-α2, IFN-α8, and IFN-ω, and the antibodies of one patient also neutralized IFN-β. All samples also neutralized the other 10 IFN-α subtypes (at least 100 pg/mL). This combination of blood autoantibodies occurs in ~0.02% and 0.6% of healthy individuals under and over 70 y of age, respectively. The presence of AAN-I-IFN before CHIKV infection therefore increased the risk of CNS disease ~850-fold relative to the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesChikungunya virusInterferon Type IChikungunya FeverMyelitisAntibodies, NeutralizingHumansFemaleAdolescentAged, 80 and overMaleMiddle AgedAdultAgedYoung AdultBrazilChildChild, PreschoolInfantMartiniqueInfant, Newborn

Stichwörter der Autor:innen

Chikungunya virusautoantibodiesencephalitismyelitistype I interferons

Substanzen

AutoantibodiesInterferon Type IAntibodies, Neutralizing

Autor:innen und Institutionen

  • St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY 10065.
  • Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris 75015, France.
  • Imagine Institute, Paris Cité University, Paris 75015, France.
  • Laboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fiocruz-Bahia, Salvador 40296-710, Brazil.
  • Caribbean Clinical Investigation Center, INSERM 2504, University Hospital of Martinique, Fort-de-France 97200, France.
  • Infectious Diseases and Tropical Medicine Unit, University Hospital of Martinique, Martinique 97200, France.

ORCID-Profile: Vu L Tran, Adrian Gervais, Marie-Mechtilde Champeaux, Maria Paula de Souza Sampaio, Mateus Santana do Rosario, Jordan D Simione, Pedro Augusto Alves, Anne Puel, Paul Bastard, Isadora Cristina de Siqueira, Aurélie Cobat, Jean-Laurent Casanova

Förderung

  • Horizon Europe
  • NCATS NIH HHS
  • French National Agency for Research
  • ANR AI2D
  • Fondation pour la Recherche Médicale (FRM)
  • Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence
  • NIAID NIH HHS
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)

Zitieren

APA

Tran, V. L., Gervais, A., Champeaux, M. M., de Souza Sampaio, M. P., Abel, S., Calmont, I., do Rosario, M. S., Schidlowski, L., Simione, J. D., Alves, P. A., Puel, A., Bastard, P., Abel, L., Prando, C., Franca, R. F. O., de Siqueira, I. C., Cabié, A., Cobat, A., Zhang, S. Y., & Casanova, J. L. (2026). Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis. Proceedings of the National Academy of Sciences, 123(34). https://doi.org/10.1073/pnas.2616897123

Vancouver

Tran VL, Gervais A, Champeaux MM, de Souza Sampaio MP, Abel S, Calmont I, et al. Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis. Proceedings of the National Academy of Sciences. 2026;123(34). doi:10.1073/pnas.2616897123

BibTeX
@article{Tran2026,
  author = {Tran, Vu L and Gervais, Adrian and Champeaux, Marie-Mechtilde and de Souza Sampaio, Maria Paula and Abel, Sylvie and Calmont, Isabelle and do Rosario, Mateus Santana and Schidlowski, Laire and Simione, Jordan D and Alves, Pedro Augusto and Puel, Anne and Bastard, Paul and Abel, Laurent and Prando, Carolina and Franca, Rafael Freitas de Oliveira and de Siqueira, Isadora Cristina and Cabié, André and Cobat, Aurélie and Zhang, Shen-Ying and Casanova, Jean-Laurent},
  title = {Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {34},
  doi = {10.1073/pnas.2616897123}
}
Kostenlos starten →